EHF expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.81330514440015E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.31987778881648E-13 |
Normal-vs-Stage2 |
2.1360690993788E-13 |
Normal-vs-Stage3 |
1.80855330711438E-13 |
Normal-vs-Stage4 |
2.00395255944841E-13 |
Stage1-vs-Stage2 |
4.878200E-02 |
Stage1-vs-Stage3 |
4.582400E-03 |
Stage1-vs-Stage4 |
1.917900E-02 |
Stage2-vs-Stage3 |
6.012600E-01 |
Stage2-vs-Stage4 |
8.829400E-01 |
Stage3-vs-Stage4 |
6.296800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.25819363208757E-13 |
Normal-vs-AfricanAmerican |
2.44704256857631E-12 |
Normal-vs-Asian |
1.7874590696465E-13 |
Caucasian-vs-AfricanAmerican |
6.237800E-02 |
Caucasian-vs-Asian |
1.119400E-01 |
AfricanAmerican-vs-Asian |
3.822100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.66786592817425E-13 |
Normal-vs-Female |
3.34399175017097E-13 |
Male-vs-Female |
6.550000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.94906329859168E-12 |
Normal-vs-Age(41-60Yrs) |
2.18491891246231E-13 |
Normal-vs-Age(61-80Yrs) |
3.3939517862791E-13 |
Normal-vs-Age(81-100Yrs) |
1.4166445794217E-13 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.659800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.042400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.539800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.213700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.840500E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.378210E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.65021338208271E-12 |
Normal-vs-Grade 2 |
4.65294469620403E-13 |
Normal-vs-Grade 3 |
1.72084568816899E-13 |
Normal-vs-Grade 4 |
2.22044604925031E-13 |
Grade 1-vs-Grade 2 |
9.265000E-01 |
Grade 1-vs-Grade 3 |
4.417400E-01 |
Grade 1-vs-Grade 4 |
5.514200E-01 |
Grade 2-vs-Grade 3 |
3.520300E-03 |
Grade 2-vs-Grade 4 |
5.156400E-02 |
Grade 3-vs-Grade 4 |
1.903050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.73872027886546E-12 |
Normal-vs-ccB subtype |
6.21613871487625E-13 |
ccA subtype-vs-ccB subtype |
6.47559999999991E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.16604512104368E-13 |
Normal-vs-N1 |
2.12152517775621E-12 |
N0-vs-N1 |
3.438400E-01 |
|
|